These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 37692153)
1. Heterozygous c.175C>T variant in Noda Y; Kido J; Misumi Y; Sugawara K; Ohori S; Fujita A; Matsumoto N; Ueda M; Nakamura K Clin Case Rep; 2023 Sep; 11(9):e7779. PubMed ID: 37692153 [TBL] [Abstract][Full Text] [Related]
2. A new case with the recurrent PURA p.(Phe233del) pathogenic variant: Expansion of the phenotype and review of the literature. Ben Issa A; Ben Ayed I; Jallouli O; Souissi A; Bouchaalla W; Ben Said M; Mallouli S; Masmoudi S; Charfi Triki C; Hadj Kacem H; Kammoun F Int J Dev Neurosci; 2023 Jun; 83(4):383-395. PubMed ID: 37204304 [TBL] [Abstract][Full Text] [Related]
3. Expanding the PURA syndrome phenotype: A child with the recurrent PURA p.(Phe233del) pathogenic variant showing similarities with cutis laxa. Cinquina V; Ciaccio C; Venturini M; Masson R; Ritelli M; Colombi M Mol Genet Genomic Med; 2021 Jan; 9(1):e1562. PubMed ID: 33275834 [TBL] [Abstract][Full Text] [Related]
4. Whole exome sequencing in family trios reveals de novo mutations in PURA as a cause of severe neurodevelopmental delay and learning disability. Hunt D; Leventer RJ; Simons C; Taft R; Swoboda KJ; Gawne-Cain M; ; Magee AC; Turnpenny PD; Baralle D J Med Genet; 2014 Dec; 51(12):806-13. PubMed ID: 25342064 [TBL] [Abstract][Full Text] [Related]
5. Expanding the clinical phenotype and genetic spectrum of PURA-related neurodevelopmental disorders. Choi SA; Lee HS; Park TJ; Park S; Ko YJ; Kim SY; Lim BC; Kim KJ; Chae JH Brain Dev; 2021 Oct; 43(9):912-918. PubMed ID: 34116881 [TBL] [Abstract][Full Text] [Related]
6. PURA syndrome in a child with severe developmental delay: a challenging diagnosis. Nogueira M; Melo C; Grangeia A; Magalhães T; Soares C; Dias R; Fonseca J; Sampaio M; Sousa R Rev Neurol; 2022 Mar; 74(5):170-173. PubMed ID: 35211951 [TBL] [Abstract][Full Text] [Related]
7. Expanding the phenotype of PURA-related neurodevelopmental disorder: a close differential diagnosis of infantile hypotonia with psychomotor retardation and characteristic facies. Mishra S; Girisha KM; Shukla A Clin Dysmorphol; 2021 Jan; 30(1):1-5. PubMed ID: 33229923 [TBL] [Abstract][Full Text] [Related]
8. [A case of combined oxidative phosphorylation deficiency 32 caused by MRPS34 gene variation and literature review]. Shen MX; Ji XN; Wu F; Gao YY; Feng S; Xie LN; Zheng P; Mao YY; Chen Q Zhonghua Er Ke Za Zhi; 2023 Jul; 61(7):642-647. PubMed ID: 37385809 [No Abstract] [Full Text] [Related]
9. Neuromuscular and Neuromuscular Junction Manifestations of the PURA-NDD: A Systematic Review of the Reported Symptoms and Potential Treatment Options. Mroczek M; Iyadurai S Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768582 [TBL] [Abstract][Full Text] [Related]
10. Expanding the neurodevelopmental phenotype of PURA syndrome. Lee BH; Reijnders MRF; Abubakare O; Tuttle E; Lape B; Minks KQ; Stodgell C; Bennetto L; Kwon J; Fong CT; Gripp KW; Marsh ED; Smith WE; Huq AM; Coury SA; Tan WH; Solis O; Mehta RI; Leventer RJ; Baralle D; Hunt D; Paciorkowski AR Am J Med Genet A; 2018 Jan; 176(1):56-67. PubMed ID: 29150892 [TBL] [Abstract][Full Text] [Related]